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Abstract
© 2016, National Academy of Sciences. All rights reserved.Non-small cell lung cancer (NSCLC)
has a 5-y survival rate of ∼16%, with most deaths associated with uncontrolled metastasis. We
screened for stem cell identity-related genes preferentially expressed in a panel of cell lines
with  h igh  versus  low  metastat ic  potent ia l ,  der ived  from  NSCLC  tumors  of
KrasLA1/+;P53R172HΔG/+  (KP)  mice.  The  Musashi-2  (MSI2)  protein,  a  regulator  of  mRNA
translation,  was  consistently  elevated  in  metastasis-competent  cell  lines.  MSI2  was
overexpressed in 123 human NSCLC tumor specimens versus normal lung, whereas higher
expression  was  associated  with  disease  progression  in  an  independent  set  of  matched
normal/primary  tumor/lymph  node  specimens.  Depletion  of  MSI2  in  multiple  independent
metastatic  murine and human NSCLC cell  lines reduced invasion and metastatic  potential,
independent of an effect on proliferation. MSI2 depletion significantly induced expression of
proteins associated with epithelial identity, including tight junction proteins [claudin 3 (CLDN3),
claudin 5 (CLDN5),  and claudin 7 (CLDN7)] and down-regulated direct translational  targets
associated with epithelial-mesenchymal transition, including the TGF-β receptor 1 (TGFβR1), the
small mothers against decapentaplegic homolog 3 (SMAD3), and the zinc finger proteins SNAI1
(SNAIL) and SNAI2 (SLUG). Overexpression of TGFβRI reversed the loss of invasion associated
with  MSI2  depletion,  whereas overexpression of  CLDN7 inhibited MSI2-dependent  invasion.
Unexpectedly,  MSI2 depletion reduced E-cadherin  expression,  reflecting a mixed epithelial-
mesenchymal phenotype. Based on this work, we propose that MSI2 provides essential support
for TGFβR1/SMAD3 signaling and contributes to invasive adenocarcinoma of the lung and may
serve as a predictive biomarker of NSCLC aggressiveness.
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